These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 514925)
21. [The use of isolated and cultivated lymphocytes of rats for the study of biotransformation of drugs]. Langner A; Müller S Pharmazie; 1991 Jun; 46(6):467-8. PubMed ID: 1763127 [No Abstract] [Full Text] [Related]
22. [Pharmacology and therapeutics. Basis of the action of drugs]. Bartol P Rev Enferm; 1981 Jan; 4(30):33-6. PubMed ID: 6914694 [No Abstract] [Full Text] [Related]
23. [Studies on the biotransformation of drugs and its significance in pharmaceutical industry]. Hansen T Nord Med; 1967 Nov; 78(47):1549-54. PubMed ID: 6075279 [No Abstract] [Full Text] [Related]
24. Soft drugs: principles and methods for the design of safe drugs. Bodor N Med Res Rev; 1984; 4(4):449-69. PubMed ID: 6387331 [No Abstract] [Full Text] [Related]
25. Fifth annual meeting and exposition. American Association of Pharmaceutical Scientists. November 4-8, 1990, Las Vegas. Abstracts. Pharm Res; 1990 Sep; 7(9 Suppl):S1-305. PubMed ID: 2395810 [No Abstract] [Full Text] [Related]
28. Fourth annual meeting and exposition. American Association of Pharmaceutical Scientists. October 22-26, 1989, Atlanta, Georgia. Abstracts. Pharm Res; 1989 Sep; 6(9 Suppl):S1-254. PubMed ID: 2780502 [No Abstract] [Full Text] [Related]
29. [Reciprocal actions between the hepatic systems in the biotransformation of drugs and alcohol (author's transl)]. Bechtel P Therapie; 1981; 36(3):257-60. PubMed ID: 7292401 [No Abstract] [Full Text] [Related]
30. Influence of formulation factors on the availability of drugs from topical preparations. Asche H; Botta L; Rettig H; Weirich EG Pharm Acta Helv; 1985; 60(8):232-7. PubMed ID: 4070318 [No Abstract] [Full Text] [Related]
31. Third annual meeting and exposition. American Association of Pharmaceutical Scientists. October 30-November 3, 1988, Orlando, Florida. Abstracts. Pharm Res; 1988 Oct; 5(10 Suppl):S5-269. PubMed ID: 3217366 [No Abstract] [Full Text] [Related]
32. [Biotransformation of drugs. 1. Problems and general metabolic routes]. Pfeifer S Pharmazie; 1968 May; 23(5):225-36. PubMed ID: 5717164 [No Abstract] [Full Text] [Related]
33. [The principle of pro-drug in drug design (author's transl)]. Guo ZR Yao Xue Xue Bao; 1979; 14(9):566-76. PubMed ID: 532661 [No Abstract] [Full Text] [Related]
34. [Effect of drugs and poisons on the synthesis and activity of microsomal enzymes participating in their metabolism]. Hanke J Folia Med Cracov; 1980; 22(3-4):263-78. PubMed ID: 7026384 [No Abstract] [Full Text] [Related]
35. Membrane transport of drugs. Martin K Curr Med Drugs; 1967 Jul; 7(11):17-28. PubMed ID: 12889098 [No Abstract] [Full Text] [Related]
39. [Pharmacokinetics of drugs in relation to age (review of the literature)]. Kuprash LP; Dzhemaĭlo VI Vrach Delo; 1981 Aug; (8):15-20. PubMed ID: 7023053 [No Abstract] [Full Text] [Related]
40. [The effect of interactions on absorption, distribution and excretion of drugs]. Dettli L Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1567-74. PubMed ID: 611881 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]